0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Foot and Mouth Disease (FMD) Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-36N6747
Home | Market Reports | Health| Public Health
Global Foot and Mouth Disease FMD Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Foot and Mouth Disease (FMD) Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-36N6747
Report
August 2025
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Foot and Mouth Disease (FMD) Vaccines- Market Size

The global market for Foot and Mouth Disease (FMD) Vaccines was estimated to be worth US$ 1068 million in 2024 and is forecast to a readjusted size of US$ 1904 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.

Foot and Mouth Disease (FMD) Vaccines- Market

Foot and Mouth Disease (FMD) Vaccines- Market

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
Global key players of foot and mouth disease (FMD) vaccines include Jinyu Group, Cavet Bio, CAHIC, Shen Lian, Biogenesis Bagó, etc. The top five players hold a share about 59%. China is the largest producer, has a share about 54%, followed by India and Europe, with share 8% and 4%, respectively. The largest market is Asia-Pacific, with a share about 74%, followed by South America and Europe, with share 16% and 4%, separately.
This report aims to provide a comprehensive presentation of the global market for Foot and Mouth Disease (FMD) Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Foot and Mouth Disease (FMD) Vaccines by region & country, by Type, and by Application.
The Foot and Mouth Disease (FMD) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K L) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Foot and Mouth Disease (FMD) Vaccines.
Market Segmentation

Scope of Foot and Mouth Disease (FMD) Vaccines- Market Report

Report Metric Details
Report Name Foot and Mouth Disease (FMD) Vaccines- Market
Forecasted market size in 2031 US$ 1904 million
CAGR 8.7%
Forecasted years 2025 - 2031
Segment by Type
  • Emergency Vaccines
  • Conventional Vaccines
Segment by Application
  • Cattle
  • Pig
  • Sheep & Goat
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Jinyu Group, Cavet Bio, CAHIC, Shen Lian, Biogenesis Bagó, Tecon Group, BIGVET Biotech, Indian Immunologicals, Boehringer Ingelheim, MSD Animal Health, CEVA, Bayer HealthCare, VECOL, Brilliant Bio Pharma, VETAL, BVI, LIMOR, ME VAC, Agrovet
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Foot and Mouth Disease (FMD) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Foot and Mouth Disease (FMD) Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Foot and Mouth Disease (FMD) Vaccines- Market size in 2031?

Ans: The Foot and Mouth Disease (FMD) Vaccines- Market size in 2031 will be US$ 1904 million.

What is the market share of major companies in Foot and Mouth Disease (FMD) Vaccines- Market?

Ans: The top five players hold a share about 59%.

What is the Foot and Mouth Disease (FMD) Vaccines- Market production share by region?

Ans: China is the largest producer, has a share about 54%, followed by India and Europe, with share 8% and 4%, respectively.

Who are the main players in the Foot and Mouth Disease (FMD) Vaccines- Market report?

Ans: The main players in the Foot and Mouth Disease (FMD) Vaccines- Market are Jinyu Group, Cavet Bio, CAHIC, Shen Lian, Biogenesis Bagó, Tecon Group, BIGVET Biotech, Indian Immunologicals, Boehringer Ingelheim, MSD Animal Health, CEVA, Bayer HealthCare, VECOL, Brilliant Bio Pharma, VETAL, BVI, LIMOR, ME VAC, Agrovet

What are the Application segmentation covered in the Foot and Mouth Disease (FMD) Vaccines- Market report?

Ans: The Applications covered in the Foot and Mouth Disease (FMD) Vaccines- Market report are Cattle, Pig, Sheep & Goat, Others

What are the Type segmentation covered in the Foot and Mouth Disease (FMD) Vaccines- Market report?

Ans: The Types covered in the Foot and Mouth Disease (FMD) Vaccines- Market report are Emergency Vaccines, Conventional Vaccines

1 Market Overview
1.1 Foot and Mouth Disease (FMD) Vaccines Product Introduction
1.2 Global Foot and Mouth Disease (FMD) Vaccines Market Size Forecast
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031)
1.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume (2020-2031)
1.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Price (2020-2031)
1.3 Foot and Mouth Disease (FMD) Vaccines Market Trends & Drivers
1.3.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
1.3.2 Foot and Mouth Disease (FMD) Vaccines Market Drivers & Opportunity
1.3.3 Foot and Mouth Disease (FMD) Vaccines Market Challenges
1.3.4 Foot and Mouth Disease (FMD) Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Foot and Mouth Disease (FMD) Vaccines Players Revenue Ranking (2024)
2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2020-2025)
2.3 Global Foot and Mouth Disease (FMD) Vaccines Players Sales Volume Ranking (2024)
2.4 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Company Players (2020-2025)
2.5 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Company (2020-2025)
2.6 Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Base and Headquarters
2.7 Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Foot and Mouth Disease (FMD) Vaccines
2.9 Foot and Mouth Disease (FMD) Vaccines Market Competitive Analysis
2.9.1 Foot and Mouth Disease (FMD) Vaccines Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Foot and Mouth Disease (FMD) Vaccines Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Emergency Vaccines
3.1.2 Conventional Vaccines
3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type
3.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value, by Type (2020-2031)
3.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Value, by Type (%) (2020-2031)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type
3.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume, by Type (2020-2031)
3.3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume, by Type (%) (2020-2031)
3.4 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cattle
4.1.2 Pig
4.1.3 Sheep & Goat
4.1.4 Others
4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application
4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value, by Application (2020-2031)
4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Value, by Application (%) (2020-2031)
4.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application
4.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume, by Application (2020-2031)
4.3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume, by Application (%) (2020-2031)
4.4 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region
5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2020-2025)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2026-2031)
5.1.4 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (%), (2020-2031)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region (2020-2025)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region (2026-2031)
5.2.4 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region (%), (2020-2031)
5.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
5.4.2 North America Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
5.5.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
5.6.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
5.7.2 South America Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
5.8.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Value
6.2.1 Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
6.2.2 Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
6.3.2 United States Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Foot and Mouth Disease (FMD) Vaccines Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
6.4.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Foot and Mouth Disease (FMD) Vaccines Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
6.5.2 China Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
6.5.3 China Foot and Mouth Disease (FMD) Vaccines Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
6.6.2 Japan Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Foot and Mouth Disease (FMD) Vaccines Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
6.7.2 South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
6.8.2 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020-2031
6.9.2 India Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
6.9.3 India Foot and Mouth Disease (FMD) Vaccines Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Jinyu Group
7.1.1 Jinyu Group Company Information
7.1.2 Jinyu Group Introduction and Business Overview
7.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.1.5 Jinyu Group Recent Development
7.2 Cavet Bio
7.2.1 Cavet Bio Company Information
7.2.2 Cavet Bio Introduction and Business Overview
7.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.2.5 Cavet Bio Recent Development
7.3 CAHIC
7.3.1 CAHIC Company Information
7.3.2 CAHIC Introduction and Business Overview
7.3.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.3.5 CAHIC Recent Development
7.4 Shen Lian
7.4.1 Shen Lian Company Information
7.4.2 Shen Lian Introduction and Business Overview
7.4.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.4.5 Shen Lian Recent Development
7.5 Biogenesis Bagó
7.5.1 Biogenesis Bagó Company Information
7.5.2 Biogenesis Bagó Introduction and Business Overview
7.5.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.5.5 Biogenesis Bagó Recent Development
7.6 Tecon Group
7.6.1 Tecon Group Company Information
7.6.2 Tecon Group Introduction and Business Overview
7.6.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.6.5 Tecon Group Recent Development
7.7 BIGVET Biotech
7.7.1 BIGVET Biotech Company Information
7.7.2 BIGVET Biotech Introduction and Business Overview
7.7.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.7.5 BIGVET Biotech Recent Development
7.8 Indian Immunologicals
7.8.1 Indian Immunologicals Company Information
7.8.2 Indian Immunologicals Introduction and Business Overview
7.8.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.8.5 Indian Immunologicals Recent Development
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Information
7.9.2 Boehringer Ingelheim Introduction and Business Overview
7.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.9.5 Boehringer Ingelheim Recent Development
7.10 MSD Animal Health
7.10.1 MSD Animal Health Company Information
7.10.2 MSD Animal Health Introduction and Business Overview
7.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.10.5 MSD Animal Health Recent Development
7.11 CEVA
7.11.1 CEVA Company Information
7.11.2 CEVA Introduction and Business Overview
7.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.11.5 CEVA Recent Development
7.12 Bayer HealthCare
7.12.1 Bayer HealthCare Company Information
7.12.2 Bayer HealthCare Introduction and Business Overview
7.12.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.12.5 Bayer HealthCare Recent Development
7.13 VECOL
7.13.1 VECOL Company Information
7.13.2 VECOL Introduction and Business Overview
7.13.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.13.5 VECOL Recent Development
7.14 Brilliant Bio Pharma
7.14.1 Brilliant Bio Pharma Company Information
7.14.2 Brilliant Bio Pharma Introduction and Business Overview
7.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.14.5 Brilliant Bio Pharma Recent Development
7.15 VETAL
7.15.1 VETAL Company Information
7.15.2 VETAL Introduction and Business Overview
7.15.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.15.5 VETAL Recent Development
7.16 BVI
7.16.1 BVI Company Information
7.16.2 BVI Introduction and Business Overview
7.16.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.16.5 BVI Recent Development
7.17 LIMOR
7.17.1 LIMOR Company Information
7.17.2 LIMOR Introduction and Business Overview
7.17.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.17.5 LIMOR Recent Development
7.18 ME VAC
7.18.1 ME VAC Company Information
7.18.2 ME VAC Introduction and Business Overview
7.18.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.18.5 ME VAC Recent Development
7.19 Agrovet
7.19.1 Agrovet Company Information
7.19.2 Agrovet Introduction and Business Overview
7.19.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Offerings
7.19.5 Agrovet Recent Development
8 Industry Chain Analysis
8.1 Foot and Mouth Disease (FMD) Vaccines Industrial Chain
8.2 Foot and Mouth Disease (FMD) Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Foot and Mouth Disease (FMD) Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Foot and Mouth Disease (FMD) Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Foot and Mouth Disease (FMD) Vaccines Market Trends
 Table 2. Foot and Mouth Disease (FMD) Vaccines Market Drivers & Opportunity
 Table 3. Foot and Mouth Disease (FMD) Vaccines Market Challenges
 Table 4. Foot and Mouth Disease (FMD) Vaccines Market Restraints
 Table 5. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Company (2020-2025)
 Table 7. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Company (2020-2025) & (K L)
 Table 8. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Foot and Mouth Disease (FMD) Vaccines Price by Company (2020-2025) & (USD/L)
 Table 10. Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Foot and Mouth Disease (FMD) Vaccines
 Table 13. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type: 2020 VS 2024 VS 2031 (K L)
 Table 22. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2020-2025) & (K L)
 Table 23. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2026-2031) & (K L)
 Table 24. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2020-2025) & (USD/L)
 Table 27. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2026-2031) & (USD/L)
 Table 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application: 2020 VS 2024 VS 2031 (K L)
 Table 34. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2020-2025) & (K L)
 Table 35. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2026-2031) & (K L)
 Table 36. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2020-2025) & (USD/L)
 Table 39. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2026-2031) & (USD/L)
 Table 40. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2020-2025) & (%)
 Table 44. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2026-2031) & (%)
 Table 45. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region (K L): 2020 VS 2024 VS 2031
 Table 46. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region (2020-2025) & (K L)
 Table 47. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region (2026-2031) & (K L)
 Table 48. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2020-2025) & (USD/L)
 Table 51. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2026-2031) & (USD/L)
 Table 52. Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Volume, (2020-2025) & (K L)
 Table 56. Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Volume, (2026-2031) & (K L)
 Table 57. Jinyu Group Company Information
 Table 58. Jinyu Group Introduction and Business Overview
 Table 59. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 60. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 61. Jinyu Group Recent Development
 Table 62. Cavet Bio Company Information
 Table 63. Cavet Bio Introduction and Business Overview
 Table 64. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 65. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 66. Cavet Bio Recent Development
 Table 67. CAHIC Company Information
 Table 68. CAHIC Introduction and Business Overview
 Table 69. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 70. CAHIC Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 71. CAHIC Recent Development
 Table 72. Shen Lian Company Information
 Table 73. Shen Lian Introduction and Business Overview
 Table 74. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 75. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 76. Shen Lian Recent Development
 Table 77. Biogenesis Bagó Company Information
 Table 78. Biogenesis Bagó Introduction and Business Overview
 Table 79. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 80. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 81. Biogenesis Bagó Recent Development
 Table 82. Tecon Group Company Information
 Table 83. Tecon Group Introduction and Business Overview
 Table 84. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 85. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 86. Tecon Group Recent Development
 Table 87. BIGVET Biotech Company Information
 Table 88. BIGVET Biotech Introduction and Business Overview
 Table 89. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 90. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 91. BIGVET Biotech Recent Development
 Table 92. Indian Immunologicals Company Information
 Table 93. Indian Immunologicals Introduction and Business Overview
 Table 94. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 95. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 96. Indian Immunologicals Recent Development
 Table 97. Boehringer Ingelheim Company Information
 Table 98. Boehringer Ingelheim Introduction and Business Overview
 Table 99. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 100. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 101. Boehringer Ingelheim Recent Development
 Table 102. MSD Animal Health Company Information
 Table 103. MSD Animal Health Introduction and Business Overview
 Table 104. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 105. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 106. MSD Animal Health Recent Development
 Table 107. CEVA Company Information
 Table 108. CEVA Introduction and Business Overview
 Table 109. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 110. CEVA Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 111. CEVA Recent Development
 Table 112. Bayer HealthCare Company Information
 Table 113. Bayer HealthCare Introduction and Business Overview
 Table 114. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 115. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 116. Bayer HealthCare Recent Development
 Table 117. VECOL Company Information
 Table 118. VECOL Introduction and Business Overview
 Table 119. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 120. VECOL Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 121. VECOL Recent Development
 Table 122. Brilliant Bio Pharma Company Information
 Table 123. Brilliant Bio Pharma Introduction and Business Overview
 Table 124. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 125. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 126. Brilliant Bio Pharma Recent Development
 Table 127. VETAL Company Information
 Table 128. VETAL Introduction and Business Overview
 Table 129. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 130. VETAL Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 131. VETAL Recent Development
 Table 132. BVI Company Information
 Table 133. BVI Introduction and Business Overview
 Table 134. BVI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 135. BVI Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 136. BVI Recent Development
 Table 137. LIMOR Company Information
 Table 138. LIMOR Introduction and Business Overview
 Table 139. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 140. LIMOR Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 141. LIMOR Recent Development
 Table 142. ME VAC Company Information
 Table 143. ME VAC Introduction and Business Overview
 Table 144. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 145. ME VAC Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 146. ME VAC Recent Development
 Table 147. Agrovet Company Information
 Table 148. Agrovet Introduction and Business Overview
 Table 149. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 150. Agrovet Foot and Mouth Disease (FMD) Vaccines Product Offerings
 Table 151. Agrovet Recent Development
 Table 152. Key Raw Materials Lists
 Table 153. Raw Materials Key Suppliers Lists
 Table 154. Foot and Mouth Disease (FMD) Vaccines Downstream Customers
 Table 155. Foot and Mouth Disease (FMD) Vaccines Distributors List
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources


List of Figures
 Figure 1. Foot and Mouth Disease (FMD) Vaccines Product Picture
 Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume (2020-2031) & (K L)
 Figure 5. Global Foot and Mouth Disease (FMD) Vaccines Sales Price (2020-2031) & (USD/L)
 Figure 6. Foot and Mouth Disease (FMD) Vaccines Report Years Considered
 Figure 7. Global Foot and Mouth Disease (FMD) Vaccines Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Foot and Mouth Disease (FMD) Vaccines Players Sales Volume Ranking (2024) & (K L)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Foot and Mouth Disease (FMD) Vaccines Revenue in 2024
 Figure 10. Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Emergency Vaccines Picture
 Figure 12. Conventional Vaccines Picture
 Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2020 VS 2024 VS 2031) & (K L)
 Figure 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2020-2031) & (USD/L)
 Figure 18. Product Picture of Cattle
 Figure 19. Product Picture of Pig
 Figure 20. Product Picture of Sheep & Goat
 Figure 21. Product Picture of Others
 Figure 22. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 23. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Market Share by Application, 2024 & 2031
 Figure 24. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2020 VS 2024 VS 2031) & (K L)
 Figure 25. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Market Share by Application, 2024 & 2031
 Figure 26. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2020-2031) & (USD/L)
 Figure 27. North America Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031) & (US$ Million)
 Figure 28. North America Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (%), 2024 VS 2031
 Figure 29. Europe Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 30. Europe Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (%), 2024 VS 2031
 Figure 31. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (%), 2024 VS 2031
 Figure 33. South America Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 34. South America Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (%), 2024 VS 2031
 Figure 35. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 36. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (%), 2024 VS 2031
 Figure 37. Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Value (%), (2020-2031)
 Figure 38. Key Countries/Regions Foot and Mouth Disease (FMD) Vaccines Sales Volume (%), (2020-2031)
 Figure 39. United States Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 40. United States Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 41. United States Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 42. Europe Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 43. Europe Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 44. Europe Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 45. China Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 46. China Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 47. China Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 48. Japan Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 49. Japan Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 50. Japan Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 51. South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 52. South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 53. South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 54. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 55. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 56. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 57. India Foot and Mouth Disease (FMD) Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 58. India Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 59. India Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 60. Foot and Mouth Disease (FMD) Vaccines Industrial Chain
 Figure 61. Foot and Mouth Disease (FMD) Vaccines Manufacturing Cost Structure
 Figure 62. Channels of Distribution (Direct Sales, and Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc